SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurocrine Biosciences (NBIX) -- Ignore unavailable to you. Want to Upgrade?


To: Icebrg who wrote (1194)1/22/2004 5:45:39 AM
From: Icebrg  Read Replies (2) | Respond to of 1834
 
Insomnia's Wake-Up Call

Alert investors have their eyes on Sepracor and Neurocrine as they bring out new drugs that battle sleeplessness -- and Sanofi's Ambien

Message 19719215

"Exploring New Paradigms in Sleep"

Two top execs from Sanofi, maker of the popular drug Ambien, talk about the challenges of staying on top in the insomnia market

Message 19719218